e-learning
resources
Barcelona 2013
Tuesday, 10.09.2013
Asthma drugs: new findings
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of resolvin D1 on leukotriene D
4
-induced constriction of rat and human bronchioles
M. Jannaway, C. Torrens, J. Warner, A. Sampson (Southampton, United Kingdom)
Source:
Annual Congress 2013 –Asthma drugs: new findings
Session:
Asthma drugs: new findings
Session type:
Thematic Poster Session
Number:
4135
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Jannaway, C. Torrens, J. Warner, A. Sampson (Southampton, United Kingdom). Effect of resolvin D1 on leukotriene D
4
-induced constriction of rat and human bronchioles. Eur Respir J 2013; 42: Suppl. 57, 4135
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Prostacyclin IP receptor activation blocks hyperosmolar-induced bronchoconstriction in isolated human small airways
Source: International Congress 2016 – Airway pharmacology: drug targets and mode of action
Year: 2016
Cysteinyl leukotrienes augment human airway smooth muscle migration
Source: Eur Respir J 2002; 20: Suppl. 38, 384s
Year: 2002
IL-13 induces glucocorticoid-insensitive hyperreactivity of human small airways
Source: International Congress 2015 – Modulating the immune system in COPD and asthma
Year: 2015
Prostaglandin E2 prevents mast cell dependent bronchoconstrictrion via the EP2 receptor in human small airways
Source: International Congress 2015 – Novel mechanisms and treatments in allergy and asthma
Year: 2015
Mevastatin ameliorates sphingosine 1-phosphate-induced inflammation in human tracheal smooth muscle cells
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Prostaglandin D
2
is a human airway smooth muscle chemoattractant
Source: Eur Respir J 2006; 28: Suppl. 50, 338s
Year: 2006
Central role of AC6 in β2 agonist induced relaxation of human airway smooth muscle
Source: International Congress 2016 – Novel insights into the treatment of COPD
Year: 2016
Serelaxin is a potent inhibitor of airway contraction and enhances β-adrenoceptor-mediated relaxation
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Secretion of hyaluronic acid is mediated by muscarinic receptors in airway smooth muscle cells of patients with COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Cyclooxygenase metabolites regulate airway smooth muscle response to PGE
2
in guinea-pig trachea
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008
Inhaled roflumilast and tadalafil supress airway reactivity and inflammation in ovalbumin-sensitized guinea pigs
Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action
Year: 2016
Endothelin receptor B protects GM-CSF mRNA from degradation in human airway smooth muscle cells
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Spontaneous relaxation in guinea pig airway smooth muscle is not regulated by leukotrienes but by prostanoids
Source: Annual Congress 2008 - Respiratory pathophysiology from cell and animal research
Year: 2008
Fevipiprant reduces airway smooth muscle mass in asthmatics via PGD2 receptor antagonism
Source: International Congress 2017 – Novel mechanisms and treatments for asthma
Year: 2017
Endothelin-1-mediated contraction of mouse small airways is resistant to salbutamol, but sensitive to rosiglitazone
Source: Annual Congress 2013 –Preclinical models for the development of new drugs for respiratory diseases
Year: 2013
Effect of cysteinyl leukotriene receptor antagonist on airway wall remodeling
Source: Eur Respir J 2002; 20: Suppl. 38, 304s
Year: 2002
Upregulation of cysteinyl leukotriene receptors CysLT
1
and CysLT
2
by TGF-β
1
and LTE
4
on human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006
A comparison of beta
2
-adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013
Physiological responses of the airway wall and lung in hyperresponsive pigs
Source: Eur Respir J 2001; 18: 935-941
Year: 2001
CCL2 release by airway smooth muscle is increased in asthma and promotes fibrocyte migration
Source: International Congress 2014 – Cell biology 2014
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept